New allelic arrangement CYP2D6*36x2 found in a Japanese poor metabolizer of debrisoquine

被引：19

作者：

Chida, M

Ariyoshi, N

Yokoi, T

Nemoto, N

Inaba, M

Kinoshita, M

Kamataki, T

机构：

[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Drug Metab, Div Pharmacobiodynam, Sapporo, Hokkaido, Japan

[2] Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Dept Toxicol, Toyama, Japan

[3] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan

[4] Otsuka Pharmaceut Co Ltd, Tokushima 77101, Japan

来源：

PHARMACOGENETICS | 2002年 / 12卷 / 08期

关键词：

CYP2D6*10; gene duplication; genotype;

D O I：

10.1097/00008571-200211000-00011

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：659 / 662

页数：4

共 10 条

[1] DEBRISOQUINE SPARTEINE HYDROXYLATION GENOTYPE AND PHENOTYPE - ANALYSIS OF COMMON MUTATIONS AND ALLELES OF CYP2D6 IN A EUROPEAN POPULATION
BROLY, F
GAEDIGK, A
HEIM, M
EICHELBAUM, M
MORIKE, K
MEYER, UA
[J]. DNA AND CELL BIOLOGY, 1991, 10 (08) : 545 - 558
[2] A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype
Chida, M
Yokoi, T
Nemoto, N
Inaba, M
Kinoshita, M
Kamataki, T
[J]. PHARMACOGENETICS, 1999, 9 (03): : 287 - 293
[3] Chida M, 1999, PHARMACOGENETICS, V9, P601
[4] ANALYSIS OF THE CYP2D6 GENE IN RELATION TO DEBRISOQUIN AND DESIPRAMINE HYDROXYLATION IN A SWEDISH POPULATION
DAHL, ML
JOHANSSON, I
PALMERTZ, MP
INGELMANSUNDBERG, M
SJOQVIST, F
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) : 12 - 17
[5] Nomenclature for human CYP2D6 alleles
Daly, AK
Brockmoller, J
Broly, F
Eichelbaum, M
Evans, WE
Gonzalez, FJ
Huang, JD
Idle, JR
IngelmanSundberg, M
Ishizaki, T
JacqzAigrain, E
Meyer, UA
Nebert, DW
Steen, VM
Wolf, CR
Zanger, UM
[J]. PHARMACOGENETICS, 1996, 6 (03): : 193 - 201
[6] The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6
Fukuda, T
Nishida, Y
Imaoka, S
Hiroi, T
Naohara, M
Funae, Y
Azuma, J
[J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 380 (02) : 303 - 308
[7] JOHANSSON I, 1994, MOL PHARM, V46, P252
[8] KIMURA S, 1989, AM J HUM GENET, V45, P889
[9] Analysis of the CΥP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population
Tateishi, T
Chida, M
Ariyoshi, N
Mizorogi, Y
Kamataki, T
Kobayashi, S
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (05) : 570 - 575
[10] A new CYP2D6 allele with a nine base insertion in exon 9 in a Japanese population associated with poor metabolizer phenotype
Yokoi, T
Kosaka, Y
Chida, M
Chiba, K
Nakamura, H
Ishizaki, T
Kinoshita, M
Sato, K
Gonzalez, FJ
Kamataki, T
[J]. PHARMACOGENETICS, 1996, 6 (05): : 395 - 401

← 1 →